SCHEMBL30419481

SCHEMBL30419481

C#CC(C)Nc1nc(=O)n(-c2cccnc2)c2cc(C(F)(F)F)cc(OC)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAT2A P31153 9/20 0.40
▸ PIK3CD O00329 3/20 0.36
▸ HTR2C P28335 3/20 0.35
▸ PRMT5 O14744 2/20 0.34
▸ ALPL P05186 1/20 0.34
▸ PDE2A O00408 3/20 0.34
▸ PDE10A Q9Y233 3/20 0.34
▸ CYP1A2 P05177 2/20 0.33
▸ HTR2A P28223 2/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ PDE6D O43924 2/20 0.33
▸ PDE6A P16499 2/20 0.33
▸ PDE6G P18545 2/20 0.33
▸ PDE6B P35913 2/20 0.33
▸ PDE6C P51160 2/20 0.33
▸ PDE6H Q13956 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ PIK3R1 P27986 1/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ PIK3CB P42338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26485299 1.00 MAT2A (0.40) MAT2APIK3CDHTR2CPRMT5ALPL
SCHEMBL26485803 0.87 MAT2A (0.50) MAT2APIK3CDPRMT5CYP3A4PIK3R1
SCHEMBL26091783 0.86 MAT2A (0.41) MAT2APIK3CDHTR2CPRMT5ALPL
SCHEMBL30420438 0.86 MAT2A (0.41) MAT2APIK3CDHTR2CPRMT5ALPL
SCHEMBL26485397 0.85 MAT2A (0.38) MAT2APIK3CDHTR2CPDE2APDE10A
SCHEMBL30420483 0.83 MAT2A (0.39) MAT2APIK3CDHTR2CPRMT5ALPL
SCHEMBL26488687 0.83 MAT2A (0.39) MAT2APIK3CDHTR2CPRMT5ALPL
SCHEMBL26488003 0.80 MAT2A (0.45) MAT2AHTR2CPRMT5ALPLPDE2A
SCHEMBL30420004 0.79 MAT2A (0.39) MAT2APIK3CDPRMT5CYP3A4
SCHEMBL26485399 0.79 MAT2A (0.39) MAT2APIK3CDPRMT5CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250042890-A1 METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOF INSILICO MEDICINE IP LIMITED (HK) 2025-02-06 — — US disclosed
EP-4419506-A1 METHIONINE ADENOSYLTRANSFERASE 2A (MAT2A) INHIBITORS AND USES THEREOF Insilico Medicine IP Limited (HK) 2024-08-28 — — EP disclosed
CN-118434722-A Methionine adenosyltransferase 2A (MAT 2A) inhibitors and uses thereof 英矽智能科技知识产权有限公司 2024-08-02 — — CN disclosed
WO-2023066283-A1 METHIONINE ADENOSYLTRANSFERASE 2A (MAT2A) INHIBITORS AND USES THEREOF INSILICO MEDICINE IP LIMITED (CN) 2023-04-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250042890-A1 METHIONINE ADENOSYLTRANSFERASE 2a (MAT2A) INHIBITORS AND USES THEREOF MAT2A, MAT2B, MAT1A MAT2A 1/4885PIK3CD 3253/4885HTR2C 1083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback